Skip to Main Content.
Human Subjects site of Office of Research Support link to UT home link to Office of Research Support

The Office of Research Support (ORS) does not administer or oversee HOP policy 5-2011 or training related to the policy. ORS administers HOP policy 7-1210, “Promoting Objectivity in Research by Managing, Reducing or Eliminating Financial Conflicts of Interest” so if you conduct research and have:

  1. Not submitted a Financial Interest Disclosure (FID), you will need to complete mandatory training and file a FID. Instructions for completing these requirements are located at
  2. Previously submitted a FID, you are not required to complete additional training nor re-disclose the same information to comply with the UTS 180/HOP 5-2011 policy requirements.   However, you may have other responsibilities under that policy.

HOP policy 5-2011 QUESTIONS? Contact the Provost’s Office or call Mike Kerker, Associate Vice Provost at (512) 471-2694.

Guidelines for Research Advertising Content

kiosk covered with flyers

The IRB must review and approve all advertisements that will be used to recruit subjects to a specific research study. Generally, advertisements used to recruit research subjects should be limited to information that a potential subject would need to determine if they are eligible and interested in participating.

The ads should include information such as:

  • the name and address of the research facility;
  • the condition or disease that will be the focus of the research;
  • the purpose of the research with reference to the fact that the study is investigational;
  • a summary of criteria for eligibility to participate;
  • the time and other commitments that will be required of the subject; and
  • the location of the study and the office to contact for further information.
  • all ads must include the statement: This study has been approved by The University of Texas at Austin Institutional Review Board.

Ads may state that reimbursement for time, travel, etc. will be given.

The ads should not:

  • contain explicit or implicit claims of safety and efficacy or equivalency or superiority to other approved treatments
  • emphasize the amount of reimbursement that subjects will receive.
  • promise a favorable outcome or benefits

When the advertisements conform to the above guidelines, they may be approved for any advertising format, e.g., posted flyers, newspapers, internet advertisements, radio/television, slides shown prior to films at movie theaters. To avoid multiple requests for review and approval, investigators should specify in their original request all advertising formats that are anticipated.